期刊文献+

厄贝沙坦与阿托伐他汀用于老年永久性房颤患者治疗中的临床效果 被引量:1

下载PDF
导出
摘要 目的:厄贝沙坦、阿托伐他汀在高龄永久性房颤病患治疗中的应用。方法:在2015年7月—2017年7月时间段里抽出200例本院内科收治的高龄永久性房颤病患进行观察,根据选用药物将病患均分为普通治疗组和联合治疗组,普通治疗组病患采取普通的房颤治疗,联合治疗组病患在进行普通房颤治疗同时结合厄贝沙坦、阿托伐他汀用药治疗,研究2组病患的纤溶凝血情况、心室率情况和血小板活化情况。结果:联合治疗组病患的纤溶凝血情况、心室率情况和血小板活化情况均优于普通治疗组,2组相比较,P<0.05。结论:对高龄永久性房颤病患行厄贝沙坦、阿托伐他汀用药治疗,可改善其纤溶凝血情况、心室率和血小板活化情况,效果显著。
作者 姜琦
出处 《影像研究与医学应用》 2018年第5期253-254,共2页 Journal of Imaging Research and Medical Applications
  • 相关文献

参考文献6

二级参考文献46

  • 1刘为民,姜锐,丁沙沙,傅威,王淑勤,李雪,康婧,吴东宁,刘波,毛文超,何丽云,刘保延.稳心颗粒治疗心房颤动的随机对照试验质量评价[J].中国中药杂志,2012,37(1):109-114. 被引量:14
  • 2Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation, 2011,123: e269-e367.
  • 3Schmieder RE, Kjeldsen SE, Julius S, et al. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens, 2008, 26:403-411.
  • 4Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med, 2002, 347: 1834-1840.
  • 5Lafuente-Lafuente C, Mouly S, Long 6 s-Tejero MA, et al. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med, 2006, 166: 719-728.
  • 6Savelieva I, Kakouros N, Konrlioaros A, et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace, 2011, 13: 308-328.
  • 7Goette A, Schon N, Kirchhof P, et al. Angiotensitl Ⅱ-antagonlst in paroxysmal atrial fibrillation (ANTIPAF) trial. Circ Arrhythm Electrophysiol, 2012, 5: 43-51.
  • 8Yamashita T, Inoue H, Okumura K, et al. Randomized trial of angiotensin Ⅱ-receptor blocker vs. dihydropirldine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM H study). Europace, 2011, 13: 473-479.
  • 9Liu T, Li L, Korantzopoulos P, et al. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol, 2008, 126:160- 170.
  • 10Rahimi K, Emberson J, Mcgale P, et aL Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randnmised controlled trials. BMJ, 2011, 342: d1250.

共引文献31

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部